A new evaluation by the International Agency for Research classifying glyphosate as being “probably carcinogenic to humans” departs from the general scientific consensus, according to the Information Technology and Innovation Foundation.
“This contradicts a strong and long standing consensus supported by a vast array of data and real world experience, and comes from an organization that rarely addresses potential pesticide carcinogenicity, perhaps because the real concerns in this area are minimal, and lie elsewhere,” said ITIF Senior Fellow Val Giddings. “The IARC statement is not the result of a thorough, considered and critical review of all the relevant data. It is beyond the pale.”
Glyphosate is the active ingredient in Monsanto’s Roundup herbicide and the company issued a release joining “fellow members of both the EU and U.S. glyphosate taskforces in our disagreement with IARC’s classification.”
Monsanto Vice President Global Regulatory Affairs Dr. Philip Miller stated that they “take great pride in the science behind, and safety of” their products and they dispute the agency’s findings for several reasons. “(T)here is no new research or data that was used; the most relevant, scientific data was excluded from review; the conclusion is not supported by scientific data; and there is no link between glyphosate and an increase in cancer when the full data set is included in a rigorous review.”
The IARC assessed the carcinogenicity of five organophosphate pesticides and in addition to glyphosate, classified the insecticides malathion and diazinon to be “probably” carcinogenic and insecticides tetrachlorvinphos and parathion as “possibly” carcinogenic.